Recent research shows that women who start the most common type of hormone therapy — estrogen plus progestin — soon after menopause have a significantly higher risk of breast cancer than those who take the hormones later or not at all. James Simon, M.D., clinical professor of Obstetrics and Gynecology in the School of Medicine and Health Sciences, says estrogen promotes the growth of almost everything, including undetectable tumors in the breasts.
Considering Hormone Replacement Therapy?
Latest News
Julie E. Bauman, MD, MPH, and Sharad Goyal, MD, were among 100 physicians and researchers selected as the 2025 recipients of the Fellow of the American Society of Clinical Oncology (FASCO) designation.
Researchers from the George Washington University School of Medicine and Health Sciences (GW SMHS) publish a new study in Nature Communications identifying a critical protein, And-1, that plays a vital role in repairing DNA damage caused by UVB radiation — the harmful rays from the sun that can…
Community leaders, health professionals, and local residents joined members of the George Washington University (GW) School of Medicine and Health Sciences to celebrate the official ribbon-cutting of the new GW Cancer Prevention and Wellness Center, located on the historic St. Elizabeths campus in…